FDA Inspection 1085327 — Samsung Bioepis Co., Ltd.
The FDA completed an inspection of Samsung Bioepis Co., Ltd. on Feb 15, 2019 in Yeonsu. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yeonsu (Korea (the Republic of))